retatrutide mechanism triple agonist glp-1 gip glucagon ly3437943 Retatrutide—A Game Changer in Obesity Pharmacotherapy Acute Contractile Effects of Glucagon-like-Peptide-1

That said, GLP-1s dont produce overnight results

How Much Should I Expect to Pay for Zepbound (Tirzepatide)

The DELIVER trial randomized 6,263 patients with symptomatic HF, 74% of whom had NYHA class II symptoms, either with HF with moderately reduced ejection fraction (HFmrEF

If you have type 2 diabetes, work with a prescriber who can monitor HbA1c, fasting glucose, and post-prandial glucose throughout the titration

When used in patients experiencing lower GI symptoms while taking GLP-1 medications, ARM allows clinicians to: Differentiate between drug-related motility effects and true pelvic floor dysfunction Quantify the severity of anorectal dysfunction to support diagnosis and treatment planning Establish a baseline prior to initiating biofeedback or behavioral therapy Monitor progress if conservative management is pursued Persistent Constipation in GLP-1 Users ARM can determine if dyssynergic defecation is contributing to delayed evacuation, guiding appropriate therapy beyond simply adjusting medication

Will I regain weight if I stop the medication